等待开盘 07-15 09:30:00 美东时间
-0.215
-3.17%
Certara partners with NVIDIA to integrate AI-driven tools into its platform, enhancing biosimulation and data analysis for life sciences. The NVIDIA BioNeMo Agent Toolkit enables specialized AI agents to work alongside Certara's models and expertise, accelerating insights across drug development stages. This collaboration aims to responsibly bring advanced AI to the industry, improving speed and scientific rigor.
07-07 12:00
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.2% on Thursday. Shares of Franklin Covey Co (NYSE:FC) fell sharply in pre-market trading after the company lowered its full-year revenue guidance, overshadowing stronger profit growth in its third quarter. Franklin Cov...
07-02 20:02
NVIDIA introduced the BioNeMo Agent Toolkit, providing domain-specific tools and skills for the agentic life sciences era. The toolkit enables AI agents, scientists, and labs to collaborate by gathering evidence, reasoning across findings, running experiments, and recommending next steps to accelerate discovery. It includes tools for protein structure prediction, molecular docking, generative chemistry, genomic analysis, and biomarker discovery. ...
06-23 13:00
Certara ( ($CERT) ) just unveiled an announcement. On June 11, 2026, Certara’s ...
06-18 06:26
CONMED (CNMD) on Wednesday announced the appointment of John Gallagher as chief financial officer, effective July 15, 2026, succeeding Todd Garner, who remains with the company in an advisory capacity...
06-18 04:53
LPRO大涨超48%,获保险经纪平台ANV溢价要约收购;OTLK涨超35%,核心产品许可申请获FDA重新受理;LION涨近14%,奈飞有意收购该公司>>
06-17 15:55
U.S. stocks were mixed at midday Tuesday as money rotated out of high-flying technology and into financials, utilities and industrials — cooling the tech-led rally as the Dow Jones Industrial Average pushed to fresh records. Meanwhile, Federal Reserve Chair Kevin Warsh prepares to gavel in his first...
06-17 01:12
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Baird analyst Joe Vruwink maintains Certara (NASDAQ:CERT) with a Neutral and lowers the price target from $7 to $6.
05-12 19:39
Earnings Call Insights: Certara (CERT) Q1 2026 Management View “First quarter performance was in line with our expectations, but does not reflect the company's potential,” said CEO Jon Resnick, adding...
05-12 01:01